Search Results - "ANGELBERGER, P"

Refine Results
  1. 1

    Imaging of highly malignant osteosarcoma with iodine-123-vascular endothelial growth factor by Holzer, G, Hamilton, G, Angelberger, P, Lai, D, Ubl, P, Dudczak, R, Dominkus, M, Li, S

    Published in Oncology (01-07-2012)
    “…Vascular endothelial growth factor (VEGF) is an important angiogenic factor, and its receptors have been shown to be overexpressed in various human carcinomas…”
    Get more information
    Journal Article
  2. 2

    Experience with indium-111 and yttrium-90-labeled somatostatin analogs by Virgolini, I, Traub, T, Novotny, C, Leimer, M, Füger, B, Li, S R, Patri, P, Pangerl, T, Angelberger, P, Raderer, M, Burggasser, G, Andreae, F, Kurtaran, A, Dudczak, R

    Published in Current pharmaceutical design (01-01-2002)
    “…The high level expression of somatostatin receptors (SSTR) on various tumor cells has provided the molecular basis for successful use of radiolabeled…”
    Get more information
    Journal Article
  3. 3

    Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy by Li, S., Peck-Radosavljevic, M., Kienast, O., Preitfellner, J., Hamilton, G., Kurtaran, A., Pirich, C., Angelberger, P., Dudczak, R.

    Published in Annals of oncology (01-08-2003)
    “…Background: Recent studies have shown that vascular endothelial growth factor (VEGF) receptor is overexpressed in vascular endothelial cells of various human…”
    Get full text
    Journal Article
  4. 4

    Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival by Linecker, A, Kermer, C, Sulzbacher, I, Angelberger, P, Kletter, K, Dudczak, R, Ewers, R, Becherer, A

    Published in Nuclear medicine (2008)
    “…The aim of the study was to determine the practicability of (18)F-FLT in tumours of the head and neck area in terms of visualization, a possible correlation…”
    Get more information
    Journal Article
  5. 5

    [123I]β-CIT and SPECT in essential tremor and Parkinson's disease by ASENBAUM, S, PIRKER, W, ANGELBERGER, P, BENCSITS, G, PRUCKMAYER, M, BRÜCKE, T

    Published in Journal of Neural Transmission (01-01-1998)
    “…Resting and postural tremor may occur in essential tremor (ET) and Parkinson's disease (PD). The aim of the present study was to investigate the cocaine…”
    Get full text
    Journal Article
  6. 6

    SPECT imaging of dopamine and serotonin transporters with [123]β-CIT. Binding kinetics in the human brain by BRÜCKE, T, KORNHUBER, J, ANGELBERGER, P, ASENBAUM, S, FRASSINE, H, PODREKA, I

    Published in Journal of Neural Transmission (01-01-1993)
    “…Single photon emission computerized tomography (SPECT) studies in non-human primates have previously shown that the cocaine derivative…”
    Get full text
    Journal Article
  7. 7

    Effects of Chemotherapeutic Agents on Expression of Somatostatin Receptors in Pancreatic Tumor Cells by Fueger, Barbara J, Hamilton, Gerhard, Raderer, Markus, Pangerl, Thomas, Traub, Tatjana, Angelberger, Peter, Baumgartner, Gerhard, Dudczak, Robert, Virgolini, Irene

    Published in The Journal of nuclear medicine (1978) (01-12-2001)
    “…Specific tumors express high amounts of receptors for somatostatin (SST), providing the basis for imaging and treatment using radiolabeled SST analogs…”
    Get full text
    Journal Article
  8. 8

    Aspects of 6-[ 18F]fluoro-L-DOPA preparation: precursor synthesis, preparative HPLC purification and determination of radiochemical purity by Füchtner, F., Angelberger, P., Kvaternik, H., Hammerschmidt, F., Simovc, B.Peric, Steinbach, J.

    Published in Nuclear medicine and biology (01-05-2002)
    “…A modified method for the synthesis of the intermediate product N-Boc-3,4-di(Boc-O)-6-iodo-L-phenylalanine ethyl ester of the [ 18F]FDOPA precursor preparation…”
    Get full text
    Journal Article
  9. 9

    Improved quality of life in patients treated with Peptide radionuclides by Traub-Weidinger, T, Raderer, M, Uffmann, M, Angelberger, P, Kurtaran, A, Leimer, M, Preitfellner, J, Dudczak, R, Virgolini, I

    Published in World journal of nuclear medicine (01-07-2011)
    “…Peptide receptor radionuclide therapy (PRRT) has recently been established as an important treatment modality for somatostatin receptor (SSTR)-positive tumors…”
    Get full text
    Journal Article
  10. 10

    β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo by PIRKER, W, ASENBAUM, S, KASPER, S, WALTER, H, ANGELBERGER, P, KOCH, G, POZZERA, A, DEECKE, L, PODREKA, I, BRÜCKE, T

    Published in Journal of Neural Transmission (01-01-1995)
    “…The cocaine analogue 2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane (beta-CIT) is a potent ligand for both dopamine- and serotonin uptake sites which in its…”
    Get full text
    Journal Article
  11. 11

    Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders by Brücke, T, Podreka, I, Angelberger, P, Wenger, S, Topitz, A, Küfferle, B, Müller, C, Deecke, L

    “…The purpose of the present study is to visualize and quantify dopamine D2 receptors in the living human brain using an 123I-labeled ligand and the single…”
    Get more information
    Journal Article
  12. 12

    Vasoactive Intestinal Peptide Receptor Scintigraphy by Virgolini, Irene, Kurtaran, Amir, Raderer, Markus, Leimer, Maria, Angelberger, Peter, Havlik, Ernst, Li, Shuren, Scheithauer, Werner, Niederle, Bruno, Valent, Peter, Eichler, Hans-Georg

    Published in The Journal of nuclear medicine (1978) (01-10-1995)
    “…This study presents the biodistribution, safety and absorbed dose of 123I-VIP administered to 18 patients with intestinal adenocarcinomas or endocrine tumors…”
    Get full text
    Journal Article
  13. 13

    Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy by Virgolini, I., Patri, P., Novotny, C., Traub, T., Leimer, M., Füger, B., Li, S.R., Angelberger, P., Raderer, M., Wogritsch, S., Kurtaran, A., Kletter, K., Dudczak, R.

    Published in Annals of oncology (2001)
    “…Based on the high number of somatostatin (SST) receptors expressed by neuroendocrine tumors, long-acting SST analogs have been successfully used for tumor…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    SPECT imaging of dopamine receptors with [123I]epidepride : characterization of uptake in the human brain by KORNHUBER, J, BRÜCKE, T, ANGELBERGER, P, ASENBAUM, S, PODREKA, I

    Published in Journal of Neural Transmission (01-01-1995)
    “…[123I]Epidepride is a new ligand for single photon emission computerized tomography (SPECT) that specifically labels D2-like dopamine receptors with very high…”
    Get full text
    Journal Article
  15. 15

    Recent developments in receptor binding radiopharmaceuticals by Angelberger, P

    Published in Wiener Klinische Wochenschrift (1991)
    “…The stereoselective and saturable binding between receptor and ligand molecules plays an important role in many biological processes. Therefore ligand-receptor…”
    Get more information
    Journal Article
  16. 16

    Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells by Li, S.R., Koller, E., Valent, P., Gludovacz, D., Yang, Q., Patri, P., Angelberger, P., Dudczak, R., Virgolini, I.

    Published in Life sciences (1973) (02-02-2001)
    “…A variety of tumor cells have been shown to express lipoprotein receptors. Recent data suggest that lipoprotein receptors may play a regulatory role in the…”
    Get full text
    Journal Article
  17. 17

    123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer by RADERER, M, KURTARAN, A, HEJNA, M, VORBECK, F, ANGELBERGER, P, SCHEITHAUER, W, VIRGOLINI, I

    Published in British journal of cancer (01-07-1998)
    “…Recent studies have shown that various gastrointestinal tumours express substantial amounts of vasoactive intestinal peptide (VIP) receptors. Based on these…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The Role of Iodine-123-Tyr-3-Octreotide Scintigraphy in the Staging of Small-Cell Lung Cancer by Leitha, T, Meghdadi, S, Studnicka, M, Wolzt, M, Marosi, C, Angelberger, P, Neumann, M, Schlick, W, Kletter, K, Dudczak, R

    Published in The Journal of nuclear medicine (1978) (01-09-1993)
    “…The purpose of this study is to investigate the role of 123I-Tyr-3-octreotide scintigraphy in staging small-cell lung cancer (SCLC), its efficacy for the…”
    Get full text
    Journal Article
  20. 20

    Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage by Virgolini, I, Rauscha, F, Lupattelli, G, Angelberger, P, Ventura, A, O'Grady, J, Sinzinger, H

    Published in European Journal of Nuclear Medicine (01-12-1991)
    “…The monitoring of local vascular kinetics after injection of autologous radiolabelled low-density lipoprotein (LDL) allows characterization of human…”
    Get full text
    Journal Article